Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price [Yahoo! Finance]
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: Yahoo! Finance
Investors are keeping an eye on these trends to gauge what is next for the company. See our latest analysis for Tango Therapeutics. Tango Therapeutics' shares have more than doubled in price year-to-date, signaling a surge of optimism after several clinical updates and partnership news in the biotech space. While the 1-year total shareholder return sits just under 100%, short-term momentum has cooled this month, which hints at some profit taking as the stock consolidates recent gains. If this kind of trajectory has you thinking bigger, now is an ideal moment to see what else is out there and discover fast growing stocks with high insider ownership With shares now trading at a sizable discount to analyst price targets, yet coming off a major run-up, the big question for investors is whether Tango's potential is still undervalued or if the market has already priced in future growth. Price-to-Sales of 15.6x: Is it justified? Tango Therapeutics currently trades at a price-to-s
Show less
Read more
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed SuccessorGlobeNewswire
- Tango Therapeutics Appoints Sung Lee to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Appoints Sung Lee to Board of DirectorsGlobeNewswire
TNGX
Earnings
- 11/4/25 - Beat
TNGX
Sec Filings
- 1/12/26 - Form 4
- 1/8/26 - Form 8-K
- 1/6/26 - Form 4
- TNGX's page on the SEC website